Biotia
Infectious disease diagnostics company using clinical metagenomics to identify pathogens.
Biotia is a biotech & life sciences company based in New York City, US. It has raised $9 million in disclosed funding. Its latest round was a Series A of $9 million in October 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $9M across 1 round. Computed only from sourced rounds.
Investors
Questions and answers
What does Biotia do?
Infectious disease diagnostics company using clinical metagenomics to identify pathogens.
How much has Biotia raised?
Biotia has raised $9 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Biotia?
Investors in Biotia include Convergent Ventures, DigitalDx Ventures, Cloquet Capital Partners, Continuum Health Ventures, I-Lab Angels and 6 more.
When and where was Biotia founded?
Biotia and is based in New York City, US.
Sources
- 1.Biotia Raises $9M to Close the Diagnostic Gap for Recurrent and Culture-Negative UTIs — AlleyWatch, Oct 2, 2026